Health policy support under extreme uncertainty: the case of cervical cancer in Cambodia
Introduction
Health policy makers in developing countries are facing severe challenges in the attempt to cover a growing population with preventive and curative health care services. Infectious diseases (e.g., malaria, dengue) remain a severe problem while chronic-degenerative diseases (e.g., diabetes mellitus, cardio-vascular diseases and cancer) emerge. Policy makers have to allocate extremely scarce resources to different levels of health care (e.g., first-line facilities, district hospitals and national hospitals), to different regions and to different interventions against the respective diseases to achieve national health objectives most efficiently (Walt 2001). However, any allocation entails opportunity costs, i.e., inefficient allocation of public health care resources results in the loss of human life.
This situation calls for evidence-based policy making, i.e., decision makers, have to know the absolute number of cases of a disease today, and in the future, as well as the relative importance of this disease in comparison to other diseases (Flessa et al. 2011). Only in this way, they can decide whether this disease should be prevented and treated by public services and whether public funds should be utilized to subsidize these services (e.g., by waiving of user-fees). There is no doubt that an evidence-based policy support is of high importance in these countries. Seeing the high complexity of disease systems, modeling becomes a must to support health policy decisions (Tan-Torres and World Health Organization 2003).
However, this policy support has to be offered under uncertainty (Pitman et al. 2012). Firstly, there is uncertainty considering biological and medical facts. Modeling requires explicit statements about the relationship of certain parameters to each other, but much remains unknown. For instance, the natural reservoir of Ebola in Africa is still not perfectly certain (Pourrut et al. 2005) which challenges all policy advice for fighting this disease (Bente et al. 2009). In addition, many biological or medical parameters are uncertain and/or short-term variables, such as infectivity rates (Wawer et al. 2005).
Secondly, the vagueness of medical care structures and data is another source of uncertainty in disease modeling. For instance, predicting the cost of treating diabetes is only feasible if the clinical pathway and the prevalence rates are known. In many countries, there are no national guidelines in place for the majority of diseases.
Thirdly, many economic facts are unknown (e.g., cost per vaccination, cost per treatment unit, etc.). In particular, the time preference rate and the associated time horizon are of high relevance for any health economic analysis (Beutels et al. 2008). In the developed world, it is assumed that the market interest rate is an appropriate proxy of the societal time preference rate (Frederick et al. 2002), but for developing countries this is questionable as the majority of decision makers have a very short time horizon and a high time preference (Sauerborn et al. 1996; Wurthwein et al. 2001). In addition, most health economic analyses use a single human life as time horizon (Pitman et al. 2012). However, in developing countries with (at least in Asia) a rapidly increasing life expectancy, it might not be easy to assess what “life-time” actually means. For these countries in demographic, epidemiological and economic transition, equilibrium models which analyze merely steady states might be insufficient as, in particular, the transition period is of interest.
Finally, health policy support frequently requires some knowledge of social patterns, such as partnership behavior. It is obvious that a model of sexually transmitted diseases will require some knowledge of relationship patterns. At the same time, basic parameters might be non-existent in the literature, e.g., intercourse frequency (Gray et al. 2001).
There is no doubt that uncertainty about biological, medical care, economic as well as social structures and parameters exists in all settings. However, the uncertainty in developing countries is more severe. Firstly, existing data are highly unreliable. Until today, the most serious problem in any modeling of (health) economic interventions in developing countries is “the almost complete unreliability of what data are available and the absence of any recent data” (Lane 1984). Although much has been invested in health information systems, reliable data are still scarce in many settings.
This statement is, secondly, in particular true for interventions that have never been performed before in a certain country, i.e., if no clinical standards, no pathways and no experiences exist. Cancer, for instance, has not been treated in public facilities of many least developed countries (World Health Organization 2002). Introducing cancer treatment will require making decisions without any country-specific data. However, data from other settings might, thirdly, not be applicable to a specific country. For instance, it was observed that the onset of diabetes in Asia is some 10 years earlier than in Europe (Ramachandran et al. 2010) so that using data from Europe might be misleading in Asian countries. Frequently, we will find a situation where no local data are available and transferability of western data is questionable.
Finally, culture might impede estimating data. For instance, recording sexual habits is difficult all over the world, but in some countries it is a taboo (Schmitt 2004). Thus, not much is known about promiscuity and homosexuality in Asian countries which makes forecasting HIV/Aids for these regions difficult.
Consequently, we face a dilemma. On one hand side, modeling is absolutely necessary to support health policy making, on the other side it is under extreme uncertainty. Decision making under uncertainty has been described in general (Hey et al. 2010) and for health systems support (Briggs et al. 2012). In principle, we have to apply five measures which may reconcile the conflict (Pitman et al. 2012). Firstly, the model building has to put all emphasis on analyzing the existing literature (including existing models) to determine structures and parameters. Secondly, the model must be calibrated until it fits existing data (as far as available) as good as possible. This means that parameters are changed within a reasonable range until the simulated results are close to the real data (Karnon and Vanni 2011).
Thirdly, results must be questioned by a number of sensitivity analyses, i.e., parameters are changed and consequences are recorded (Sharif et al. 2012). Fourthly, the simulator must run different scenarios to see the consequences of structural and parameter changes. Finally, all results must be analyzed thoroughly and interpreted with great caution. With many different scenarios and sensitivity analyses, the scientist cannot provide one outcome parameter as the only true answer. Instead, he will provide insights and bands of cost-effectiveness that are robust against changes. In this way, he can provide policy makers with the evidence required for decision making.
In the following, we will present a case study exemplifying these principles. We have chosen the case of cervical cancer in Cambodia as it shows all characteristics of modeling under extreme uncertainty. We had to face this uncertainty when we gave consultancy to the Ministry of Health in Phnom Penh concerning the introduction of non-communicable diseases into the basic health care package of this country. For this purpose, the next section provides some background on cervical cancer and the situation in Cambodia. Afterwards, the system dynamics model is presented. The fourth section presents the results of different simulations. Finally, these results are discussed under the focus of health policy support under extreme uncertainty.
Section snippets
Case study: cervical cancer in Cambodia
Cervix uteri carcinoma (CUC) is a malignant neoplasm that is almost exclusively caused by an infection with a specific virus, the human papilloma virus (HPV). This disease is the second most common cancer in women worldwide with some 500,000 new cases and 270,000 deaths annually (WHO 2014b). Consequently, several authors modeled the effectiveness and cost-effectiveness of interventions against HPV and CUC. In their systematic review of 2009, Marra et al. (2009) found 101 publications presenting
Model
Based on the categorization of Kim et al., the model presented here is dynamic (i.e., “population within the model can interact”), open (“populations are allowed to enter the model”), deterministic (“transition rates are fixed”) and aggregate (“using values reflecting population averages”) (Kim et al. 2008). It simulates the natural history of cervix uteri carcinoma from infection to death. It concentrates on cancerous high-risk HPV types (Kahn 2009; Lowy and Schiller 2006), in particular type
Basic results
The analysis follows the standards of health economic evaluation (Caro et al. 2012; Edejer 2003; Husereau et al. 2013; Pitman et al. 2012; Tilson et al. 2006; von der Schulenburg 2007). The basic simulation assumes that no intervention (no treatment, no screening, and no vaccination) is done in Cambodia. This is (almost) the reality of Cambodia today for the vast majority of the population.
Figure 4 shows the incidence of pre-invasive and invasive cancer cases in Cambodia as well as the number
Discussion
The results of the simulations indicate an immense burden of cervical cancer for the population of Cambodia. This country has progressed in the epidemiological transition so that more and more women will be suffering unless interventions are planned and implemented now. Our simulations clearly indicate that there are cost-effective interventions that could be financed within limited budgets. The findings have to be translated into policy decisions.
However, recommendations for the health policy
Conflict of interest
The authors declare that they have no conflict of interest, i.e., no secondary interests exist or have influenced our professional judgment or actions.
Acknowledgments
The authors would like to thank their colleagues from the Ministry of Health of Cambodia, of the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) and from EPOS/KfW for their support and input. This research has been partly financed by the German Federal Ministry for Economic Cooperation and Development (BMZ) through the Social Health Protection (SHP) Project implemented by the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH.
D. Dietz: deceased on 3 January 2015.
References (76)
- et al.
Funding of drugs: do vaccines warrant a different approach?
Lancet Infect Dis
(2008) Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6
Value Health
(2012)Health and economic outcomes of HPV 16, 18 vaccination in 72 GAVI-eligible countries
Vaccine
(2008)Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda
Lancet
(2001)- et al.
A system dynamics model for AIDS policy support in Tanzania
Eur J Oper Res
(1993) Modeling cervical cancer prevention in developed countries
Vaccine
(2008)Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5
Value Health
(2012)The natural history of Ebola virus in Africa
Microbes Infect
(2005)- et al.
Diabetes in Asia
Lancet
(2010) Human papillomavirus and cervical cancer
Lancet
(2007)
Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa
Gynecol Oncol
Disease modeling for Ebola and Marburg viruses
Dis Models Mech
Indoor air pollution in developing countries: a major environmental and public health challenge
Bull World Health Organ
Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys
PLoS One
Modeling good research practices—overview a report of the ISPOR-SMDM modeling good research practices task force-1
Med Decis Making
Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection
BMC Infect Dis
Basing care reforms on evidence: the Kenya health sector costing model
BMC health Serv Res
Time discounting and time preference: a critical review
J Econ Lit
Estimating the cost of cervical cancer screening in five developing countries
Cost Eff Resour Alloc
Policy analysis of cervical cancer screening strategies in low-resource settings
JAMA J Am Med Assoc
Cost-effectiveness of cervical-cancer screening in five developing countries
N Engl J Med
The descriptive and predictive adequacy of theories of decision making under uncertainty/ambiguity
J Risk Uncertain
A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya
Bull World Health Organ
Consolidated health economic evaluation reporting standards (CHEERS) statement
BMC Med
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
BMC Med
HPV vaccination for the prevention of cervical intraepithelial neoplasia
N Engl J Med
Calibrating models in economic evaluation
Pharmacoeconomics
Screening for cervical cancer in India: how much will it cost? A trial based analysis of the cost per case detected
Int J Cancer
Prophylactic human papillomavirus vaccines
J Clin Investig
Costs and benefits of different strategies to screen for cervical cancer in less-developed countries
J Natl Cancer Inst
Effectiveness and cost effectiveness of human papillomavirus vaccine
Pharmacoeconomics
Cited by (7)
Place matters – the spatial diffusion of contagious diseases
2023, International Journal of Business and Systems ResearchAnalytics in developing countries: methods, applications, and the impact on the UN Sustainable Development Goals
2022, International Transactions in Operational ResearchOvercoming COVID-19 in China despite shortcomings of the public health system: what can we learn?
2021, Health Economics ReviewCosting of cesarean sections in a government and a non-governmental hospital in cambodia—a prerequisite for efficient and fair comprehensive obstetric care
2020, International Journal of Environmental Research and Public HealthCosting for universal health coverage: Insight into essential economic data from three provinces in Cambodia
2019, Health Economics ReviewPredicting the cost of diseases in resource-poor countries
2017, Medical Ethics, Prediction, and Prognosis: Interdisciplinary Perspectives